PASSION FOR IDEAS

Actelion

Indication for pulmonary arterial hypertension (PAH), a life-threatening disorder which severely compromises the function of the lungs and heart. IPO on SWX in April 2000.

Recent News

Company Info

Country:	Switzerland
Industry:	LS
Sector:	biotechnology
Status:	Realized
Vehicle:	Genevest

Key persons

Jean-Paul Clozel , CEO; Andre Mueller, former CFO, vice Chairman of the Board

Company website

www.actelion.com

Endeavour Vision Team

Sven Lingjaerde

partner of the European Tech Tour

"The partners have been very supportive of our approach and stepped in to add value when needed. I would strongly recommend them as investors."
Didier Cowling, Founder and CEO, Kuros Biosurgery AG